Inhibition of AURKA destabilizes glioblastoma primary cilia and sensitizes cells to tumor treating fields (TTFields) in vitro and ex vivo

被引：0
|
作者：
Tian, Jia
Mallinger, Julianne
Shi, Ping
Ling, Dahao
Deleyrolle, Loic
Lin, Min
Khoshbouei, Habibeh
Sarkisian, Matthew
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5961
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5961
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Tumor treating fields (TTFields) targeted self assembling nanoparticles for pancreatic cancer treatment: In vitro and in vivo assessment
    Desai, Preshita Prafulla
    Prabhu, Sunil
    CANCER RESEARCH, 2024, 84 (06)
  • [42] Tumor treating fields (TTFields) reduce migration and invasion properties of human glioma cancer cells in vitro
    Schneiderman, Rosa S.
    Shteingauz, Anna
    Giladi, Moshe
    Voloshin, Tali
    Porat, Yaara
    Munster, Mijal
    Blat, Roni
    Kirson, Eilon D.
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2016, 76
  • [43] Efficacy of 150 kHz tumor treating fields (TTFields) and cisplatin or pemetrexed for the treatment of mesothelioma cells in vitro
    Weinberg, U.
    Munster, M.
    Gotlib, K.
    Schneiderman, R. S.
    Porat, Y.
    Sela, T. Voloshin
    Davidi, S.
    Shteingauz, A.
    Kaynan, N.
    Zeevi, E.
    Giladi, M.
    Kirson, E.
    Kinzel, A.
    Palti, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] Glioblastoma multiforme (GBM) and beyond: By-passing the blood brain barrier (BBB) via Tumor Treating Fields (TTFields) in vivo
    Salvador, E.
    Kessler, A.
    Hoermann, J.
    Burek, M.
    Brami, C. Tempel
    Sela, T. Voloshin
    Giladi, M.
    Ernestus, R. I.
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S81 - S82
  • [45] Glioblastoma multiforme (GBM) and beyond: By-passing the blood brain barrier (BBB) via Tumor Treating Fields (TTFields) in vivo
    Salvador, E.
    Kessler, A. F.
    Hormann, J.
    Burek, M.
    Brami, C. T.
    Sela, T., V
    Giladi, M.
    Ernestus, R. -, I
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S64 - S64
  • [46] Valproic acid (VPA) combined with Tumor Treating Fields (TTFields) in vitro decreases cellular proliferation and increases clonogenic potential of glioblastoma (GBM) cells.
    Michelhaugh, Sharon K.
    Coombe, Susan
    Degen, Katherine E.
    Mittal, Sandeep
    CANCER RESEARCH, 2021, 81 (13)
  • [47] PROSTAGLANDIN E RECEPTOR 3 (PTGER3) REGULATES RESISTANCE TO TUMOR TREATING FIELDS (TTFIELDS) IN GLIOBLASTOMA CELLS
    Chen, Dongjiang
    Le, Son
    Hutchinson, Tarun
    Tran, David
    NEURO-ONCOLOGY, 2021, 23 : 77 - 77
  • [48] The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and sorafenib shows In vitro and in vivo efficacy in hepatocellular carcinoma
    Davidi, S.
    Gotlib, K.
    Zeevi, E.
    Shnaiderman, R.
    Voloshin, T.
    Giladi, M.
    Kinzel, A.
    Weinberg, U.
    Kirson, E.
    Palti, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [49] Safety and Effectiveness of Tumor Treating Fields (TTFields; 150 kHz) and Sorafenib Combination Treatment in Hepatocellular Carcinoma In Vitro and In Vivo
    Voloshin, T.
    Davidi, S.
    Brami, C. Tempel
    Munster, M.
    Gotlib, K.
    Zeevi, E.
    Schneiderman, R. S.
    Giladi, M.
    Kinzel, A.
    Kirson, E. D.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E652 - E652
  • [50] In vitro and in vivo efficacy of the combined treatment of 150 khz tumor treating fields (TTFields) and sorafenib in hepatocellular carcinoma.
    Weinberg, Uri
    Davidi, Shiri
    Gotlib, Karnit
    Zeevi, Einav
    Tempel-Brami, Catherine
    Schneiderman, Rosa S.
    Voloshin, Tali
    Giladi, Moshe
    Kinzel, Adrian
    Kirson, Eilon David
    Palti, Yoram
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345